171 related articles for article (PubMed ID: 37935665)
1. The tumor-enriched small molecule gambogic amide suppresses glioma by targeting WDR1-dependent cytoskeleton remodeling.
Qu J; Qiu B; Zhang Y; Hu Y; Wang Z; Guan Z; Qin Y; Sui T; Wu F; Li B; Han W; Peng X
Signal Transduct Target Ther; 2023 Nov; 8(1):424. PubMed ID: 37935665
[TBL] [Abstract][Full Text] [Related]
2. WDR1 Promotes Cell Growth and Migration and Contributes to Malignant Phenotypes of Non-small Cell Lung Cancer through ADF/cofilin-mediated Actin Dynamics.
Yuan B; Zhang R; Hu J; Liu Z; Yang C; Zhang T; Zhang C
Int J Biol Sci; 2018; 14(9):1067-1080. PubMed ID: 29989053
[TBL] [Abstract][Full Text] [Related]
3. A novel lncRNA ARST represses glioma progression by inhibiting ALDOA-mediated actin cytoskeleton integrity.
Sun J; He D; Fu Y; Zhang R; Guo H; Wang Z; Wang Y; Gao T; Wei Y; Guo Y; Pang Q; Liu Q
J Exp Clin Cancer Res; 2021 Jun; 40(1):187. PubMed ID: 34099027
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound-triggered drug delivery for glioma therapy through gambogic acid-loaded nanobubble-microbubble complexes.
Wang F; Dong L; Liang S; Wei X; Wang Y; Chang L; Guo K; Wu H; Chang Y; Yin Y; Wang L; Shi Y; Yan F; Li N
Biomed Pharmacother; 2022 Jun; 150():113042. PubMed ID: 35658212
[TBL] [Abstract][Full Text] [Related]
5. Cyclovirobuxine D inhibits cell proliferation and migration and induces apoptosis in human glioblastoma multiforme and low‑grade glioma.
Zhou L; Tang H; Wang F; Ou S; Wu T; Fang Y; Xu J; Guo K
Oncol Rep; 2020 Mar; 43(3):807-816. PubMed ID: 32020219
[TBL] [Abstract][Full Text] [Related]
6. ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells.
Gao Z; Xu J; Fan Y; Zhang Z; Wang H; Qian M; Zhang P; Deng L; Shen J; Xue H; Zhao R; Zhou T; Guo X; Li G
J Exp Clin Cancer Res; 2022 Nov; 41(1):323. PubMed ID: 36380368
[TBL] [Abstract][Full Text] [Related]
7. YAP signaling is involved in WDR1-regulated proliferation and migration of non-small-cell lung cancer cells.
An R; Wang J; Chen X; Xu R; Hu J; Liu Z; Wei C; Zhang C; Yuan B
Exp Biol Med (Maywood); 2022 Sep; 247(18):1619-1629. PubMed ID: 35861209
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional targeting daunorubicin plus quinacrine liposomes, modified by wheat germ agglutinin and tamoxifen, for treating brain glioma and glioma stem cells.
Li XT; Ju RJ; Li XY; Zeng F; Shi JF; Liu L; Zhang CX; Sun MG; Lou JN; Lu WL
Oncotarget; 2014 Aug; 5(15):6497-511. PubMed ID: 25153726
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional targeting vinorelbine plus tetrandrine liposomes for treating brain glioma along with eliminating glioma stem cells.
Li XT; Tang W; Jiang Y; Wang XM; Wang YH; Cheng L; Meng XS
Oncotarget; 2016 Apr; 7(17):24604-22. PubMed ID: 27029055
[TBL] [Abstract][Full Text] [Related]
10. High expression of WDR1 in primary glioblastoma is associated with poor prognosis.
Xu H; Chen Y; Tan C; Xu T; Yan Y; Qin R; Huang Q; Lu C; Liang C; Lu Y; Wang H; Chen J
Am J Transl Res; 2016; 8(2):1253-64. PubMed ID: 27158412
[TBL] [Abstract][Full Text] [Related]
11. A Gambogic Acid-Loaded Delivery System Mediated by Ultrasound-Targeted Microbubble Destruction: A Promising Therapy Method for Malignant Cerebral Glioma.
Dong L; Li N; Wei X; Wang Y; Chang L; Wu H; Song L; Guo K; Chang Y; Yin Y; Pan M; Shen Y; Wang F
Int J Nanomedicine; 2022; 17():2001-2017. PubMed ID: 35535034
[TBL] [Abstract][Full Text] [Related]
12. The Wdr1-LIMK-Cofilin Axis Controls B Cell Antigen Receptor-Induced Actin Remodeling and Signaling at the Immune Synapse.
Bolger-Munro M; Choi K; Cheung F; Liu YT; Dang-Lawson M; Deretic N; Keane C; Gold MR
Front Cell Dev Biol; 2021; 9():649433. PubMed ID: 33928084
[TBL] [Abstract][Full Text] [Related]
13. Targeting of glioma stem-like cells with a parthenolide derivative ACT001 through inhibition of AEBP1/PI3K/AKT signaling.
Hou Y; Sun B; Liu W; Yu B; Shi Q; Luo F; Bai Y; Feng H
Theranostics; 2021; 11(2):555-566. PubMed ID: 33391492
[TBL] [Abstract][Full Text] [Related]
14. Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis.
Bota DA; Alexandru D; Keir ST; Bigner D; Vredenburgh J; Friedman HS
J Neurosurg; 2013 Dec; 119(6):1415-23. PubMed ID: 24093630
[TBL] [Abstract][Full Text] [Related]
15. SEPT7 overexpression inhibits glioma cell migration by targeting the actin cytoskeleton pathway.
Hou M; Liu X; Cao J; Chen B
Oncol Rep; 2016 Apr; 35(4):2003-10. PubMed ID: 26846171
[TBL] [Abstract][Full Text] [Related]
16. Hippocampal Wdr1 Deficit Impairs Learning and Memory by Perturbing F-actin Depolymerization in Mice.
Wang J; Kou XL; Chen C; Wang M; Qi C; Wang J; You WY; Hu G; Chen J; Gao J
Cereb Cortex; 2019 Sep; 29(10):4194-4207. PubMed ID: 30590446
[TBL] [Abstract][Full Text] [Related]
17. Autophagy inhibition promotes gambogic acid-induced suppression of growth and apoptosis in glioblastoma cells.
Luo GX; Cai J; Lin JZ; Luo WS; Luo HS; Jiang YY; Zhang Y
Asian Pac J Cancer Prev; 2012; 13(12):6211-6. PubMed ID: 23464433
[TBL] [Abstract][Full Text] [Related]
18. Blood-Brain Barrier- and Blood-Brain Tumor Barrier-Penetrating Peptide-Derived Targeted Therapeutics for Glioma and Malignant Tumor Brain Metastases.
Chen L; Zeng D; Xu N; Li C; Zhang W; Zhu X; Gao Y; Chen PR; Lin J
ACS Appl Mater Interfaces; 2019 Nov; 11(45):41889-41897. PubMed ID: 31615203
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-Cas9-Mediated TIM3 Knockout in Human Natural Killer Cells Enhances Growth Inhibitory Effects on Human Glioma Cells.
Morimoto T; Nakazawa T; Matsuda R; Nishimura F; Nakamura M; Yamada S; Nakagawa I; Park YS; Tsujimura T; Nakase H
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33800561
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of glioblastoma growth and angiogenesis by gambogic acid: an in vitro and in vivo study.
Qiang L; Yang Y; You QD; Ma YJ; Yang L; Nie FF; Gu HY; Zhao L; Lu N; Qi Q; Liu W; Wang XT; Guo QL
Biochem Pharmacol; 2008 Mar; 75(5):1083-92. PubMed ID: 18070617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
